Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt

v3.20.1
Long-Term Debt
3 Months Ended
Mar. 31, 2020
Long-Term Debt  
Long-Term Debt

9.Long-Term Debt

Long-term debt is summarized below:

l

March 31,

December 31,

2020

2019

Term Loan, net of debt discount of $683 and $781 at March 31, 2020 and December 31, 2019, respectively

$

225,302

$

245,787

Less current maturities

1,938

22,143

Long-term debt before deferred financing costs

223,364

223,644

Deferred financing costs, net

1,356

1,563

Long-term debt, net

$

222,008

$

222,081

At March 31, 2020, the Company had outstanding borrowings under its term loan credit agreement of $225,302, outstanding borrowings on its revolving credit facility of $30,000, and remaining borrowing availability of $59,160.  At December 31, 2019, the Company had outstanding borrowings under its term loan credit agreement of $245,787, no outstanding borrowings on its revolving credit facility and remaining borrowing availability of $99,352.  

In accordance with the senior credit facilities, the Company is required to make additional principal prepayments over the above scheduled payments under certain conditions. This includes, in the case of the term loan facility, 100% of the net cash proceeds of certain asset sales, certain insurance or condemnation events, certain debt issuances, and, within 150 days of the end of each fiscal year, 50% of consolidated excess cash flow including a deduction for certain distributions (which percentage is reduced to 0% upon the achievement of certain leverage ratio thresholds), for such fiscal year. Consolidated excess cash flow is defined in the senior credit facilities as consolidated adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) plus a consolidated working capital adjustment, less the sum of repayments of debt and capital expenditures (subject to certain adjustments), interest and taxes paid in cash, management fees and certain restricted payments (including certain dividends or distributions). Consolidated working capital adjustment is defined in the senior credit facilities as the change in working capital, defined as current assets, excluding cash and cash equivalents, less current liabilities, excluding the current portion of long-term debt.  As of March 31, 2020, the Company was not required to make additional excess cash flow payments during fiscal 2020. The Company made a voluntary payment of $20,000 on its debt on January 31, 2020.

On June 13, 2019 the Company entered into an interest rate swap agreement to reduce its exposure to interest rate volatility. The interest rate swap has a notional amount of $175,000 effective for the period May 31, 2019 through May 31, 2024. The Company may have counterparty credit risk resulting from the interest rate swap, which it monitors on an on-going basis. The risk lies with one global financial institution. Under the interest rate swap agreement, the Company will either receive or make payments on a monthly basis based on the differential between 2.495% and LIBOR (with a LIBOR floor of 1.0%). The interest rate swap was previously accounted for as a cash flow hedge. During the three months ended March 31, 2020, the swap was determined to be ineffective. As a result, the swap was dedesignated on March 19, 2020, and the remaining losses currently included in Accumulated other comprehensive loss on the Condensed Consolidated Balance Sheets will be amortized into interest expense on a straight line basis through the life of the swap. The amount expected to be amortized from Accumulated other comprehensive loss into earnings in the next twelve months is $2,991. A mark-to-market adjustment of $1,413 was recorded in earnings on March 31, 2020 related to the swap.

The interest rate swap’s negative fair value at March 31, 2020 was $13,876, of which $3,570 and $10,306 are included in Accrued expenses and other current liabilities and Other long-term liabilities on the Condensed Consolidated Balance Sheet, respectively.  The interest rate swap’s negative fair value at December 31, 2019 was $6,736, of which $1,522 and $5,214 are included in Accrued expenses and other current liabilities and Other long-term liabilities on the Condensed Consolidated Balance Sheet, respectively.